I am bullish on CorMedix Inc. (NASDAQ: CRMD ) due to its promising niche market and strong financials. The stock is undervalued, warranting a buy recommendation. The company’s product pipeline points to its bright outlook, as the company looksFirst Principles Partners is an equity research analyst specializing in technology, innovation, and sustainability investment. My unique approach, "First Principles," involves breaking down complex problems to their most basic elements in terms of financial and technol ...